Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 2:45 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2785–2808 of 3,580 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: patch Clear all

Conditions: Intracranial Arterial Aneurysm
Interventions: Additional scan time on standard MR angiography; Radiation
Lead sponsor: Lahey Clinic; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Burlington, Massachusetts

Conditions: Amblyopia
Interventions: IO-therapy Glasses, patch; Device
Lead sponsor: Salus University; Other
Eligibility: 3 Years to 8 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Elkins Park, Pennsylvania

Conditions: Healthy
Interventions: Micropatch; Device
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years to 50 Years
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Human Immunodeficiency Virus, Human Papillomavirus-Related Anal Squamous Cell Carcinoma, High-Grade Squamous Intraepithelial Lesions
Interventions: Biospecimen Collection, Questionnaires; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 21 Years and older
Enrollment: 217 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: MelanomaCutaneous Melanoma Resectable, Melanoma
Interventions: RP2 (vusolimogene oderparepvec), Nivolumab, Definitive Surgical Resection; Drug · Procedure
Lead sponsor: Yana Najjar; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2033
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Atherosclerosis, Angioplasty, Peripheral Arterial Disease
Interventions: Paclitaxel; Drug
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 80 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Primary Spontaneous Pneumothorax
Interventions: Autologous Blood Patch; Procedure
Lead sponsor: Rush University Medical Center; Other
Eligibility: 13 Years to 18 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Melanoma (Skin), Pigmented Skin, Nevus
Interventions: Not listed
Lead sponsor: DermTech; Other
Eligibility: 21 Years and older
Enrollment: 652 participants
Timeline: 2019 – 2022
U.S. locations: 2
States / cities: Chevy Chase, Maryland • Salt Lake City, Utah

Conditions: Cardiac Arrhythmia
Interventions: Zio Monitor; Device
Lead sponsor: iRhythm Technologies, Inc.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 2
States / cities: San Francisco, California • Deerfield, Illinois

Conditions: Coronary Artery Disease, Coronary Bifurcation Lesions
Interventions: Percutaneous Coronary Interbention; Procedure
Lead sponsor: Minneapolis Heart Institute Foundation; Other
Eligibility: 18 Years and older
Enrollment: 4,000 participants
Timeline: 2020 – 2030
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Pain, Postoperative
Interventions: Lidoderm 5 % Topical Patch, Sham Topical Patch; Drug · Other
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 89 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Cartilage Injury, Knee Injuries, Arthropathy of Knee, Cartilage Damage, Knee Pain Swelling
Interventions: 7 Tesla Magnetic Resonance Imaging Test; Diagnostic Test
Lead sponsor: The Methodist Hospital Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Precancerous Conditions
Interventions: Erlotinib & Celecoxib; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Skin Lesion
Interventions: Ultrasound; Procedure
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Tetraplegia, Hypothermia, Mild Cognitive Impairment
Interventions: Midodrine Hydrochloride, Cool Temperature; Drug · Other
Lead sponsor: James J. Peters Veterans Affairs Medical Center; Federal
Eligibility: 18 Years to 68 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2022
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Breast Cancer
Interventions: Diclofenac epolamine patch; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Colon Cancer, Polyp, Adenoma
Interventions: Chromocolonoscopy; Procedure
Lead sponsor: Indiana University; Other
Eligibility: 50 Years and older
Enrollment: 792 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 3
States / cities: Indianapolis, Indiana • Stony Brook, New York

Conditions: Neurofibromatosis 1
Interventions: Deoxycholic Acid, Polidocanol, 1064nm Nd:YAG laser, 755nm Alexandrite Laser; Drug · Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 80 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, Non-Melanoma Skin Cancers
Interventions: IFx-Hu2.0; Biological
Lead sponsor: TuHURA Biosciences, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 4
States / cities: Los Angeles, California • Tampa, Florida • Boston, Massachusetts + 1 more

Conditions: Knee Injuries, Joint Surface Knee Lesions
Interventions: Marketed Product - MP01, Other Surgical Treatments; Device · Procedure
Lead sponsor: Smith & Nephew, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2034
U.S. locations: 6
States / cities: Parker, Colorado • Washington D.C., District of Columbia • Indianapolis, Indiana + 3 more

Conditions: Carcinoma of the Head and Neck
Interventions: Talimogene Laherparepvec, Pembrolizumab; Drug · Biological
Lead sponsor: Amgen; Industry
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 8
States / cities: Newark, Delaware • Chicago, Illinois • Louisville, Kentucky + 3 more

Conditions: Smoking Cessation
Interventions: Brief physician advice, nicotine patch, Individually Tailored Behavioral Skills training; Behavioral · Drug
Lead sponsor: The Miriam Hospital; Other
Eligibility: 18 Years and older
Timeline: 1996 – 1999
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Psoriasis, Plaque Psoriasis
Interventions: ARQ-151 cream 0.3%; Drug
Lead sponsor: Arcutis Biotherapeutics, Inc.; Industry
Eligibility: 2 Years to 5 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 16
States / cities: Mountain Brook, Alabama • Scottsdale, Arizona • Fountain Valley, California + 10 more

Conditions: Vitiligo
Interventions: Rapamycin, Placebo; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 13 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Charleston, South Carolina

Search by objective public record fields.

Analysis Of Intracranial Artery Lesions Using 2-D/3D Phase Contrast MR

Efficacy of Intermittent Occlusion Therapy Glasses for Amblyopia

Micropore Closure Kinetics at Various Body Sites

Anal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH)

Neoadjuvant RP2 + Nivolumab in Patients With Melanoma

Local Paclitaxel Delivery for SFA Disease

Autologous Blood Patch for Primary Spontaneous Pneumothorax

Sample Collection Study in Patients With Suspected Melanoma Utilizing DermTech's Non-invasive Adhesive Patch Biopsy Kits

Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II

Progress Bifurcation Global Registry

Post-Op Lidocaine Patch

7T MRI to Evaluate Cartilage Defects in the Knee

Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor

Ultrasound in Diagnosing Patients With Skin Lesions

Thermoregulation and Cognition During Cool Ambient Exposure in Tetraplegia

Test Uniformity of Transdermal Drug Delivery to Breast Using Diclofenac Epolamine

Chromocolonoscopy for the Detection of Flat Adenomas in Routine Colorectal Cancer Screening.

Efficacy of Skin Cooling in Reducing Pain Associated With Non-invasive Treatments of Neurofibromatosis Type 1 Cutaneous Neurofibromas

Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers

Knee Cartilage Repair Registry

Talimogene Laherparepvec With Pembrolizumab for Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY232 / KEYNOTE-137)

Motivation and Nicotine Patch Treatment for Under-served Smokers

Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216)

Daily Topical Rapamycin for Vitiligo